Literature DB >> 29131706

Alzheimer's Disease-Current Status and Future Directions.

Deepshikha Bhardwaj1, Connie Mitra1, Chandrakala Aluganti Narasimhulu1, Aladdin Riad1, Mitsushita Doomra1, Sampath Parthasarathy1.   

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder of the brain. The presence of amyloid-beta (Aβ) plaques, neurofibrillary tangles (NFTs), loss of neurons, synapses, and altered sensory perceptions, including memory loss, delineate AD. However, the cause of AD is not clearly known. Several genetic and nongenetic factors have been implicated in the disease. Of the genes, the ɛ4 allele of apolipoprotein E is the largest known genetic risk factor of AD. This review article focuses on the various genetic and other predisposing factors that account for AD, pathophysiology of the disease, and the mechanisms by which Aβ plaques and NFTs are formed and could affect AD brain. In addition, recent advances and current diagnostics available for AD patients are detailed. As oxidative stress has been implicated in the etiology of the disease, special emphasis is given for nutrition based antioxidant therapies and interventional strategies for reducing/treating AD.

Entities:  

Keywords:  amyloid precursor protein; amyloid-beta plaques; apolipoprotein E; neurofibrillary tangles; neuroimaging; nutrition

Mesh:

Substances:

Year:  2017        PMID: 29131706     DOI: 10.1089/jmf.2017.0093

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  8 in total

1.  Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.

Authors:  Jing Wang; Xialin Chen; Weirong Bai; Zhenzhong Wang; Wei Xiao; Jingbo Zhu
Journal:  Neurochem Res       Date:  2021-05-14       Impact factor: 3.996

2.  Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population.

Authors:  Nesrine Ben Salem; Sami Boussetta; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Narjes Mokni; Imene Mahmoud; Samia Younes; Nizar Daouassi; Mahbouba Frih-Ayed; Afef Hammami; Amel Ben Ammar Elgaaied; Agustín Ruiz; Lotfi Cherni
Journal:  Mol Biol Rep       Date:  2021-12-01       Impact factor: 2.316

3.  New Hopes for Treatment of Alzheimer's Disease.

Authors:  Shahin Akhondzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jan-Mar

4.  Systems Pharmacological Approach to Investigate the Mechanism of Acori Tatarinowii Rhizoma for Alzheimer's Disease.

Authors:  Zhenyan Song; Fang Yin; Biao Xiang; Bin Lan; Shaowu Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-27       Impact factor: 2.629

5.  The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.

Authors:  Ling Hu; Rong Zhang; Qiong Yuan; Yinping Gao; Mary Q Yang; Chunxiang Zhang; Jiankun Huang; Yufei Sun; William Yang; Jack Y Yang; Zhen-Li Min; Jing Cheng; Youping Deng; Xiamin Hu
Journal:  BMC Syst Biol       Date:  2018-12-14

6.  The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.

Authors:  Zhuoran Li; Na Yang; Xiuxia Lei; Chuying Lin; Nan Li; Xinqing Jiang; Xinhua Wei; Banglao Xu
Journal:  J Clin Lab Anal       Date:  2019-06-14       Impact factor: 2.352

7.  Exploring the Mechanism of Panax notoginseng Saponins against Alzheimer's Disease by Network Pharmacology and Experimental Validation.

Authors:  Yixuan Jiang; Shanliang Li; Xiaoqin Xie; Hemei Li; Panling Huang; Bocun Li; Lini Huo; Jing Zhong; Yuqing Li; Xing Xia
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-30       Impact factor: 2.629

8.  Downregulation of miR-33 Has Protective Effect Against Aβ₂₅₋₃₅-Induced Injury in SH-SH-SY5Y Cells.

Authors:  Xiaoping Wang; Xiaojia Li; Bin Huang; Lili Yang; Kai Chen; Dongdong Zhao; Xiangdong Luo; Yingji Wang
Journal:  Med Sci Monit       Date:  2020-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.